Literature DB >> 30617699

Active and secondhand smoke exposure throughout life and DNA methylation in breast tumors.

Catherine L Callahan1,2, Matthew R Bonner3, Jing Nie3, Youjin Wang3,4, Meng-Hua Tao5, Peter G Shields6, Catalin Marian6,7, Kevin H Eng8, Maurizio Trevisan9, Jo L Freudenheim3.   

Abstract

PURPOSE: Tobacco smoke exposure has been associated with altered DNA methylation. However, there is a paucity of information regarding tobacco smoke exposure and DNA methylation of breast tumors.
METHODS: We conducted a case-only analysis using breast tumor tissue from 493 postmenopausal and 225 premenopausal cases in the Western New York Exposures and Breast Cancer (WEB) study. Methylation of nine genes (SFN, SCGB3A1, RARB, GSTP1, CDKN2A, CCND2, BRCA1, FHIT, and SYK) was measured with pyrosequencing. Participants reported their secondhand smoke (SHS) and active smoking exposure for seven time periods. Unconditional logistic regression was used to estimate odds ratios (OR) of having methylation higher than the median.
RESULTS: SHS exposure was associated with tumor DNA methylation among postmenopausal but not premenopausal women. Active smoking at certain ages was associated with increased methylation of GSTP1, FHIT, and CDKN2A and decreased methylation of SCGB3A1 and BRCA1 among both pre- and postmenopausal women.
CONCLUSION: Exposure to tobacco smoke may contribute to breast carcinogenesis via alterations in DNA methylation. Further studies in a larger panel of genes are warranted.

Entities:  

Keywords:  Breast cancer; DNA methylation; Epigenetics; Secondhand smoke; Tobacco

Mesh:

Substances:

Year:  2019        PMID: 30617699      PMCID: PMC6697076          DOI: 10.1007/s10552-018-1102-4

Source DB:  PubMed          Journal:  Cancer Causes Control        ISSN: 0957-5243            Impact factor:   2.532


  49 in total

1.  Association of GSTP1 CpG islands hypermethylation with poor prognosis in human breast cancers.

Authors:  Takashi Arai; Yasuo Miyoshi; Seung Jin Kim; Tetsuya Taguchi; Yasuhiro Tamaki; Shinzaburo Noguchi
Journal:  Breast Cancer Res Treat       Date:  2006-06-22       Impact factor: 4.872

2.  Secondhand smoke exposure in early life and the risk of breast cancer among never smokers (United States).

Authors:  Matthew R Bonner; Jing Nie; Daikwon Han; John E Vena; Peter Rogerson; Paola Muti; Maurizio Trevisan; Stephen B Edge; Jo L Freudenheim
Journal:  Cancer Causes Control       Date:  2005-08       Impact factor: 2.506

3.  Benzopyrene exposure disrupts DNA methylation and growth dynamics in breast cancer cells.

Authors:  Bekim Sadikovic; David I Rodenhiser
Journal:  Toxicol Appl Pharmacol       Date:  2006-06-30       Impact factor: 4.219

Review 4.  Tobacco smoke carcinogens and breast cancer.

Authors:  Stephen S Hecht
Journal:  Environ Mol Mutagen       Date:  2002       Impact factor: 3.216

5.  Early loss of Fhit in the respiratory tract of rodents exposed to environmental cigarette smoke.

Authors:  Francesco D'Agostini; Alberto Izzotti; Roumen Balansky; Nicola Zanesi; Carlo M Croce; Silvio De Flora
Journal:  Cancer Res       Date:  2006-04-01       Impact factor: 12.701

6.  Tumor-specific methylation in bronchial lavage for the early detection of non-small-cell lung cancer.

Authors:  Hojoong Kim; Young Mi Kwon; Jin Seuk Kim; Haengbyoung Lee; Jung-Ho Park; Young Mog Shim; Joungho Han; Joobae Park; Duk-Hwan Kim
Journal:  J Clin Oncol       Date:  2004-06-15       Impact factor: 44.544

7.  Role of the protein tyrosine kinase Syk in regulating cell-cell adhesion and motility in breast cancer cells.

Authors:  Xiaoying Zhang; Ulka Shrikhande; Bethany M Alicie; Qing Zhou; Robert L Geahlen
Journal:  Mol Cancer Res       Date:  2009-05-12       Impact factor: 5.852

8.  Cancer DNA methylation: molecular mechanisms and clinical implications.

Authors:  Michael T McCabe; Johann C Brandes; Paula M Vertino
Journal:  Clin Cancer Res       Date:  2009-06-09       Impact factor: 12.531

9.  DNA hypermethylation and clinicopathological features in breast cancer: the Western New York Exposures and Breast Cancer (WEB) Study.

Authors:  Meng Hua Tao; Peter G Shields; Jing Nie; Amy Millen; Christine B Ambrosone; Stephen B Edge; Shiva S Krishnan; Catalin Marian; Bin Xie; Janet Winston; Dominica Vito; Maurizio Trevisan; Jo L Freudenheim
Journal:  Breast Cancer Res Treat       Date:  2008-05-08       Impact factor: 4.872

10.  Frequent aberrant DNA methylation of ABCB1, FOXC1, PPP2R2B and PTEN in ductal carcinoma in situ and early invasive breast cancer.

Authors:  Aslaug Aa Muggerud; Jo Anders Rønneberg; Fredrik Wärnberg; Johan Botling; Florence Busato; Jovana Jovanovic; Hiroko Solvang; Ida Bukholm; Anne-Lise Børresen-Dale; Vessela N Kristensen; Therese Sørlie; Jörg Tost
Journal:  Breast Cancer Res       Date:  2010-01-07       Impact factor: 6.466

View more
  4 in total

1.  DNA Methylation in RARβ Gene as a Mediator of the Association Between Healthy Lifestyle and Breast Cancer: A Case-Control Study.

Authors:  Xuan Wang; Yupeng Liu; Hongru Sun; Anqi Ge; Dapeng Li; Jinming Fu; Yan Li; Da Pang; Yashuang Zhao
Journal:  Cancer Manag Res       Date:  2020-06-18       Impact factor: 3.989

Review 2.  Air pollution-induced epigenetic changes: disease development and a possible link with hypersensitivity pneumonitis.

Authors:  Suranjana Mukherjee; Sanjukta Dasgupta; Pradyumna K Mishra; Koel Chaudhury
Journal:  Environ Sci Pollut Res Int       Date:  2021-09-08       Impact factor: 4.223

3.  Global Trends in Death, Years of Life Lost, and Years Lived With Disability Caused by Breast Cancer Attributable to Secondhand Smoke From 1990 to 2019.

Authors:  Zejin Ou; Yunxia Gao; Diwei Jiang; Jiaxin Cui; Yixian Ren; Shihao Tang; Danping Duan; Danfeng Yu; Zhi Wang
Journal:  Front Oncol       Date:  2022-03-29       Impact factor: 6.244

Review 4.  DNA methylation signature of passive smoke exposure is less pronounced than active smoking: The Understanding Society study.

Authors:  Paige M Hulls; Frank de Vocht; Yanchun Bao; Caroline L Relton; Richard M Martin; Rebecca C Richmond
Journal:  Environ Res       Date:  2020-07-31       Impact factor: 6.498

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.